Answers are grounded in this paper and cite their sources.
Hinokitiol (β-thujaplicin), a naturally occurring tropolone compound isolated from Cupressaceae family plants, exhibits a broad-spectrum of pharmacological activities, including antimicrobial, anticancer, antiviral, antiparasitic, antioxidant, anti-inflammatory, and neuroprotective effects. Extensive in vitro and in vivo studies have confirmed its therapeutic promise, particularly against cancer, infectious diseases, and metabolic disorders. However, its clinical translation remains limited due to major biopharmaceutical challenges such as poor aqueous solubility, low absorption, instability, and restricted bioavailability. This review uniquely integrates insights into hinokitiol’s chemistry, structural modification, biosynthetic pathways, and pharmacological mechanisms with a critical evaluation of drug delivery innovations aimed at overcoming these biopharmaceutical limitations, rather than presenting a disease-centric catalog of reported activities. Structurally modified glycosylated hinokitiol derivatives and phytosome-based oral delivery systems illustrate improved stability, solubility and pharmacokinetics profiles. In addition, we summarize emerging directions, including bioengineering-based synthesis, systems pharmacology, and the design of novel derivatives with improved pharmacokinetic profiles, discussed within the context of their translational relevance. While preclinical evidence highlights its broad therapeutic potential, successful clinical application will depend on addressing unresolved challenges, a comprehensive toxicological assessment, and explicit clinical studies to validate safety, efficacy, and clinical feasibility. Collectively, these directions will enable the progression of hinokitiol from promising laboratory findings to a clinically relevant and industrially viable multifunctional natural medicine.
No takes yet. Share an insight, caveat, or question.
Hashmi et al. (2026) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: